There is no commercial support for this activity.

About the speaker

Nolan Williams, MD, is an Associate Professor within the Department of Psychiatry and Behavioral Sciences and Director of the Stanford Brain Stimulation Lab. He has a broad background in clinical neuroscience and is triple board-certified in general neurology, general psychiatry, and behavioral neurology & neuropsychiatry. Themes of his work include examining the use of spaced learning theory in the application of neurostimulation techniques, development and mechanistic understanding of rapid-acting antidepressants, and identifying objective biomarkers that predict neuromodulation responses in treatment-resistant neuropsychiatric conditions. His work resulted in an FDA clearance for the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. He has published papers in high-impact peer-reviewed journals, including Nature Medicine, Nature Mental Health, Brain, American Journal of Psychiatry, and the Proceedings of the National Academy of Science. Results from his studies have gained widespread attention in Science and NEJM Journal Watch and have been featured in multiple news outlets, including TIME, US News & World Report, Newsweek, Scientific American, ABC, NBC, CBS, NPR, and more. Dr. Williams received two NARSAD Young Investigator Awards in 2016 and 2018, as well as the 2019 Gerald L. Klerman Award. He was honored with the Stanford University Chairman’s Award for Advancing Science in 2019. In 2020, he received the National Institute of Mental Health Biobehavioral Research Award for Innovative New Scientists as well as the One Mind Bipolar Research Award. In 2020, 2021 and 2022, he received the BBRF Leading Research Achievements Awards, and in 2024, he received the A.E. Bennett Award from the Society of Biological Psychiatry.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services, or off-label uses of product(s) during this presentation.

Nolan Williams, MD, reports a relevant financial relationship with Magnus as a consultant and equity stockholder. The content of the educational activity is related to the business line or product of the company; therefore, the activity is not eligible for ACCME credit. All other relationships have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Michael Young, MD, Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis J. Marino, Jr., MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, April Sobiech, LCSW-C, Latia Suite, LCSW-C, Rachel Smolowitz, PhD, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.